Abstract

Mutations in SPG11, leading to loss of spatacsin function, impair the formation of membrane tubules in lysosomes and cause lysosomal lipid accumulation. However, the full nature of lipids accumulating in lysosomes and the physiological consequences of such accumulation are unknown. Here we show that loss of spatacsin inhibits the formation of tubules on lysosomes and prevents the clearance of cholesterol from this subcellular compartment. Accumulation of cholesterol in lysosomes decreases cholesterol levels in the plasma membrane, enhancing the entry of extracellular calcium by store-operated calcium entry and increasing resting cytosolic calcium levels. Higher cytosolic calcium levels promote the nuclear translocation of the master regulator of lysosomes TFEB, preventing the formation of tubules and the clearance of cholesterol from lysosomes. Our work reveals a homeostatic balance between cholesterol trafficking and cytosolic calcium levels and shows that loss of spatacsin impairs this homeostatic equilibrium.

Highlights

  • Mutations in SPG11, leading to loss of spatacsin function, impair the formation of membrane tubules in lysosomes and cause lysosomal lipid accumulation

  • We demonstrate that the resulting modification in cytosolic calcium levels contributes to the impairment of lysosome tubulation and accumulation of cholesterol in late endosomes/lysosomes and that this process is TFEB-dependent

  • Since mutations in SPG11 cause neurodegeneration[3], we evaluated the impact of loss of spatacsin function on cholesterol distribution in neuronal models

Read more

Summary

Introduction

Mutations in SPG11, leading to loss of spatacsin function, impair the formation of membrane tubules in lysosomes and cause lysosomal lipid accumulation. We show that the loss of spatacsin function and the associated inhibition of tubule formation in late endosomes/ lysosomes leads to the accumulation of cholesterol in this compartment, due to its impaired export out of the organelle. This results in a decrease in the level of plasma membrane cholesterol that disturbs intracellular calcium homeostasis. We demonstrate that the resulting modification in cytosolic calcium levels contributes to the impairment of lysosome tubulation and accumulation of cholesterol in late endosomes/lysosomes and that this process is TFEB-dependent

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.